Disposable Syringe Market Size & Share 2025 – 2034

Disposable Syringe Market Size

The global disposable syringe market size was valued at USD 16.3 billion in 2024 and is anticipated to reach USD 30 billion by 2034, growing at a CAGR of 6.4% from 2025 to 2034. A catalyst for market growth is the growing incidence of lifestyle-related health complications such as cardiovascular disease and obesity.

The demand is further intensified by the increasing prevalence of chronic disease, including diabetes, hypertension and autoimmune disorders, which require frequent injectable treatment. According to the Indian Council of Medical Research over 101 million people in India are living with diabetes in 2023. The growing burden of such disease is driving consistent demand for single-use syringes used in insulin administration, drug delivery and vaccination programs.
 

Furthermore, the rising occurrence of infectious disease outbreaks such as measles, dengue, and influenza is contributing significantly to the volume of immunization and emergency care services. The World Health Organization (WHO) in 2024 reported global measles cases reached 10.3 million in 2023 resulting in over 1,07,500 deaths, reflecting urgent need for safe vaccination practices, which heavily rely on disposable and auto-disposable syringes.
 

The disposable syringe market size was valued at USD 19.6 billion in 2023 and is estimated to grow at a CAGR of 10.9% from 2024 to 2032, comprises single use syringe designed for administering medications, vaccines and other injectable therapies across healthcare. These are widely used due to their role in preventing cross contamination and ensuring safe, sterile drug delivery.
 

Disposable Syringe Market Trends

• The growing prevalence of chronic disease across the globe is majorly stimulating the disposable syringe industry. With the rising cases of diabetes, cardiovascular diseases and autoimmune disorder the demand for injectable drug delivery has increased significantly. These therapies typically require safe, single-use delivery devices such as disposable syringes to prevent contamination and maintain dosage accuracy.
   
• According to the WHO, as of 2024 over 830 million people worldwide are living with diabetes, affecting almost 14% of the global adult population. This sharp increase has escalated the demand for insulin syringes and associated injection devices, especially in outpatient and home-based care settings.
• Further, the rise in immunization programs and infectious disease control efforts has brought back the necessity for auto-disable and safety syringes in both pediatric and adult population.
   
• For instance, the United Nations Children’s Fund (UNICEF) reported in 2021, the donation of 13 million syringes to assist the national vaccination drive of Jordan, highlighting the growing dependency on sterile, single-use syringe for safe and efficient vaccine administration.
   
• Additionally, the technological improvements in syringe design and materials are shaping purchasing preferences and regulatory alignment. Innovations such as needle stick prevention features and retractable plungers are being increasingly adopted by hospitals and clinics to ensure safety for both patient and healthcare professional.
   

Disposable Syringe Market Analysis

In 2021, the global market for disposable syringe was valued at USD 13.8 billion. The following year, it saw a slight increase to USD 14.6 billion, and by 2023, the market further climbed to USD 15.4 billion. Based on product, the global market is segmented into conventional and safety syringes. The conventional syringes segment accounted for the highest market share and was valued at USD 8.7 billion in 2024.
 

• Conventional disposable syringes continue to lead the market as the most widely used type across hospitals, clinics, and home care. These syringes are used for routine injections, drawing blood and administering IV medication. Their affordable cost, simple design, and wide availability make them the preferred option for healthcare professionals in both developing and developed countries.
   
• In many countries, conventional syringes are purchased in bulk for government healthcare programs, outpatient services and vaccination drives. Their practicality and low price point make them essential for large scale use.
   
• During major global healthcare campaigns, conventional syringes are heavily used. According to UNICEF, which is the largest buyer of syringes in the world, the organization delivers 900 million syringes each year for children’s vaccinations alone. This underlines the crucial role of conventional syringes in supporting essential public health initiatives around the world.
   
• Although safety syringes are gaining popularity due to increased awareness of needle stick injuries and cross contamination risks, conventional syringes still account for the majority of use, their continued dominance is expected due to cost effectiveness and ease.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on application, the global disposable syringe market is categorized into vaccinations, blood collection, drug delivery and other applications. The vaccination segment dominated the market and is anticipated to grow at a CAGR of 6.8% through 2034.
 

• The vaccination segment is the most dominating application stimulated by large scale immunization programs globally. A major push came from the COVAX initiative, a global partnership led by WHO, CEPI to ensure equitable COVID-19 vaccine access. According to UNICEF and WHO, COVAX delivered nearly 2 billion vaccine doses to 146 countries by December 2023, and each dose required a single dose disposable syringe, significantly boosting syringe demand worldwide.
   
• Also, the newer vaccines such as HPV, updated COVID-19 boosters and combined pediatric formulations are being rolled out in many countries increasing the volume and frequency of vaccinations.
   
• This growth trend is directly tied to higher consumption of single use syringes across both public and private health sectors.
   

Based on end use, the global disposable syringe market is classified into hospitals and clinics, diagnostic laboratories, ambulatory surgical centers, and other end users. In 2024, the hospitals and clinics segment held the highest market share and is expected to showcase significant growth over the analysis period.
 

• The dominance of hospitals and clinics is due to the high volume of injections received in these places.
   
• Disposable syringes are used by health services in several tasks including vaccination, blood sample collection, and medicine, along with intravenous infusion.
   
• With the growing number of patients seeking treatment and the emergence of more chronic diseases, we need more and more modern hospitals and clinics. The demand of syringes will continually increase.
   
• Furthermore, the need for disposable syringes is further enhanced by rigorous infection control measures as well as safety protocols, which will solidify the segment’s market share.
   

The North America dominated global disposable syringe market with a revenue share of 42.5% in 2024, attributed to the high volume of surgical procedures performed in U.S. and Canada, widespread availability of healthcare infrastructure.
 

The U.S. market for disposable syringe was valued at USD 5.5 billion and USD 5.8 billion in 2021 and 2022, respectively. The market size reached USD 6.5 billion in 2024, growing from USD 6.1 billion in 2023.
 

• The U.S. is home to 6,093 hospitals as reported by the American Hospital Association, fostering the use of conventional and safety syringes.
   
• Additionally, the Center for Disease Control and Prevention (CDC) reported in 2024 that 1 in 31 hospitalized patients experience a healthcare associated infection daily, prompting strict infection prevention protocols which result in the use of single use syringes to reduce the cross contamination.
   
• Moreover, needlestick injuries remain a major concern across all types of healthcare settings from hospitals and outpatient surgery centers to nursing homes and cosmetic clinics. The National Institutes of Health (NIH) in 2023 reported that the U.S. sees an estimated 6,00,000 needlestick injuries annually, with over half going unreported.
   
• These incidences primarily affect the nurses, surgeons, EMTs, and lab personnel. The high frequency of such injuries reinforces the critical need for single-use disposable syringes to protect healthcare workers and maintain compliance with safety protocols.
   

Europe disposable syringe market accounted for USD 4.38 billion in 2024 and is anticipated to show lucrative growth over the forecast period.
 

• Rising incidences of age-related surgical procedures and increasing chronic disease prevalence continues to increase demand for disposable syringe in Europe.
   
• For example, the growing prevalence of chronic conditions, especially diabetes, has significantly impacted syringe consumption across Europe. In 2019 approximately 60 million Europeans, about 10% of adults, were living with diabetes, fueling the demand for insulin delivery syringes.
   
• In fact, in 2019, diabetes related healthcare expenditure in Europe reaches Euro 147.9 billion, surpassing the Euro 103 billion spent on cancer, according to the European Federation of Pharmaceutical Industries and Association (EFPIA).
   
• With healthcare expenditure already surpassing, Europe remains a high vale region for syringe manufacturers aiming to meet the increasing needs for both chronic care and preventive health programs.
   

Germany disposable syringe market is anticipated to witness considerable growth over the analysis period.
 

• The country’s well-established healthcare practices and research institutions, along with their emphasis on high-quality medical equipment, contribute to the widespread adoption of disposable syringes.
   
• According to the German Federal Statistical Office, the number of individuals aged 67 or older is projected to rise by 22% between 2020-2035, increasing from 16 million to 20 million.
   
• This aging trend is expected to significantly increase healthcare needs, especially for chronic disease management, routine therapies that require frequent syringe use.
   
• Additionally, Germany’s focus on hospital safety protocols, combined with increasing use of syringes in outpatient and elderly care supports the market growth.
   

The Asia Pacific disposable syringe market is anticipated to grow at the highest CAGR of 7% during 2025 to 2034.
 

• The market in the Asia Pacific region is growing rapidly due to the growing burden of chronic diseases, all of which require surgical interventions.
  .
• Countries such as China, India and Japan are at the forefront of this trend, contributing significantly to the rising procedural volume.
   

• In Japan, the high proportion of elderly population is linked with increases demand for surgical procedures. For example, in 2023 projections from the World Economic Forum revealed that 1 in 10 people in Japan are aged 80 years and above which was about one-third of the population.
   

• Additionally, as healthcare standards continue to rise in the region, the need for innovative technologies will further propel the market for disposable syringes in the region.
   

China disposable syringe market is predicted to grow significantly over the forecast period.
 

• China’s aging population is a stimulator for this market. According to China’s National Bureau of Statistics (NBS), as of 2021, there were approximately 264.02 million people aged 60 and over, accounting for 18.70% of the population. Of these 190.64 million were aged 65 and above.
   
• This demographic shift raises the burden of chronic diseases such as diabetes, cardiovascular conditions and arthritis all of which require ongoing injectable treatments, simultaneously increasing the demand for disposable syringes.
   
• Furthermore, the presence of numerous local manufacturers in the country enhances market growth, making it one of the most cost-competitive and scalable contributors to the global market.
   

Brazil is experiencing significant growth in the Latin America disposable syringe market.
 

• Brazil has high volume of private hospitals which enhances demand for surgical procedures. With the majority of hospitals being private and known for performing a high share of surgical procedures, there is steady demand for disposable syringes across the private sector.
   
• Additionally, the presence of several international as well as local companies in the country further aid in the market growth.
   

In Middle East and Africa, the Saudi Arabia disposable syringe market is poised to witness substantial growth during the forecast period.
 

• The growing surgical procedure volume supports disposable syringe demand. According to the Ministry of Health (MOH), 177,744 routine surgeries were performed in MOH hospitals during the first half of 2023.
   
• Hospital expansion under Vision 2030 boosts surgical capacity. The MOH is investing heavily in infrastructure, increasing capacity and surgical throughput, which in turn increases the procurement of disposable syringes.
   

Disposable Syringe Market Share

Competition in the disposable syringe industry is marked by well-established companies, regional manufacturer and emerging firms. The top five companies, Becton, Dickinson and Company, Terumo Corporation, Nipro Corporation, B.Braun Melsungen AG, and Hindustan Syringes and Medical Devices accounts for 45% of the global market share. These key players focus on various strategies such as acquisitions, business expansion, new launches to sustain their competitive edge.
 

Additionally, there are several local and regional players operating in the market who are boosting competition by providing affordable options at lower costs. These players are also involved in several strategies such as mergers, acquisitions, and novel product launches to expand their product offerings.
 

Disposable Syringe Market Companies

Few of the prominent players operating in the disposable syringe industry include:

• Agilent Technologies
• B Braun Melsungen
• Baxter International
• Becton, Dickinson and Company
• Braun Medical
• Chris Merchant
• Fresenius Kabi
• Henke-Sass, Wolf
• Hindustan Syringes & Medical Devices
• Kohope Medical
• Medtronic
• Nipro Corporation
• Terumo Corporation
• Ultimed
• Vita Needle Company
   
• Becton, Dickinson and Company is a prominent player in the global disposable syringe market, recognized for its extensive portfolio of innovative and high-quality syringe products designed to meet diverse healthcare needs.
   
• Medtronic holds a significant share in the disposable syringe industry through its comprehensive surgical solutions portfolio. Medtronic emphasizes RESEARCH AND DEVELOPMENT and product development offerings in disposable syringes.
   

Disposable Syringe Industry News

• In March 2024, BD has announced an increase in domestic production to meet the growing demand for syringes in the U.S. healthcare market. This strategic move aims to support the nation's healthcare needs effectively. By enhancing domestic production, BD is expected to strengthen its supply chain resilience, reduce dependency on imports, and improve its market position in the disposable syringe segment.
   
• In March 2024, Hindustan Syringes and Medical Devices (HMD) launched "Dispojekt," a single-use syringe equipped with a safety needle designed to prevent needlestick injuries (NSIs). This innovation aims to enhance safety standards in healthcare settings by reducing the risk of accidental injuries among medical professionals. The introduction of "Dispojekt" is expected to strengthen HMD's position in the disposable syringe industry by addressing critical safety concerns.
   

The disposable syringe market research report includes in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 - 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Conventional syringes
• Safety syringes
  • Retractable safety syringes
  • Non-retractable safety syringes

Market, By Application

• Vaccination
• Blood collection
• Drug delivery
• Other applications

 Market, By End Use

• Hospitals and clinics
• Diagnostic laboratories
• Ambulatory surgical centers (ASCs)
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea 
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE